scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051054438 |
P356 | DOI | 10.1038/BMT.2011.257 |
P698 | PubMed publication ID | 22246089 |
P50 | author | Ali Bazarbachi | Q57964105 |
P2093 | author name string | A Bacigalupo | |
M A Kharfan-Dabaja | |||
Z K Otrock | |||
F Geara | |||
R A Mahfouz | |||
P2860 | cites work | Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation | Q33183745 |
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party | Q33886206 | ||
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita | Q35128245 | ||
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. | Q53330217 | ||
Dyskeratosis congenita | Q58388056 | ||
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita | Q71045172 | ||
Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation | Q73112262 | ||
Unusual complications after bone marrow transplantation for dyskeratosis congenita | Q77476844 | ||
Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin | Q81552159 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dyskeratosis congenita | Q3709312 |
hematology | Q103824 | ||
P304 | page(s) | 1254-1255 | |
P577 | publication date | 2012-01-16 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita | |
P478 | volume | 47 |
Q36782745 | A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation |
Q90485045 | Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia |
Q46177519 | Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. |
Q87154630 | Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita |
Q34094121 | The diagnosis and treatment of dyskeratosis congenita: a review |
Search more.